Nurse Practitioner, Family · Albany, NY
NPI
1306843958
Since 2005
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
736 Madison Ave
Albany, NY, 12208
Phone (518) 463-3169
Groups this clinician bills Medicare through
Medicare paid, 2024
$230K
9,218 services
Medicare patients, 2024
1,246
Average age 75
Drug cost, 2024
$1.6M
2,306 prescriptions
Company payments, 2025
$1,023
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nancy H Trzcinski was code 17003 (destruction skin lesion), 5,189 times for 754 patients. In total Nancy H Trzcinski billed 9,218 services in 43 codes, and Medicare paid $230K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 5,189 | 754 | $3.82 | $20K |
| 99213 Office E&M - Established | Office | 1,888 | 1,172 | $53.30 | $101K |
| 17000 Destruction Skin Lesion | Office | 1,100 | 859 | $36.50 | $40K |
| 17004 Destruction Skin Lesion | Office | 354 | 286 | $92.19 | $33K |
| 17360 Skin | Office | 193 | 86 | $63.42 | $12K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 140 | 34 | $0.72 | $100 |
| 99203 Office E&M - New | Office | 70 | 70 | $62.99 | $4,409 |
| 96372 Injection Administration | Office | 48 | 38 | $8.69 | $417 |
| 99214 Office E&M - Established | Office | 38 | 25 | $66.17 | $2,514 |
| 17281 Destruction Skin Lesion | Office | 34 | 31 | $96.03 | $3,265 |
| 17262 Destruction Skin Lesion | Office | 29 | 26 | $89.67 | $2,601 |
| 11104 Skin Biopsy | Office | 16 | 15 | $82.13 | $1,314 |
| 17261 Destruction Skin Lesion | Office | 13 | 12 | $76.46 | $994 |
| 17272 Destruction Skin Lesion | Office | 12 | 12 | $107.81 | $1,294 |
By year: 2022 $202K for 7,321 services; 2023 $207K for 7,685 services; 2024 $230K for 9,218 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nancy H Trzcinski prescribed most often to Medicare patients was Triamcinolone Acetonide, with 389 prescriptions and refills. In total Nancy H Trzcinski wrote 2,306 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 389 | 426 | 262 | $4,086 |
| Metronidazole Generic | 201 | 217 | 87 | $18K |
| Clindamycin Phosphate Generic | 185 | 218 | 81 | $7,197 |
| Ketoconazole Generic | 116 | 124 | 71 | $2,236 |
| Fluocinonide Generic | 98 | 102 | 53 | $4,933 |
| Valacyclovir Valacyclovir Hcl | 97 | 114 | 43 | $1,466 |
| Ciclopirox Ciclopirox Olamine | 89 | 97 | 62 | $3,625 |
| Dupixent Pen Dupilumab | 82 | 111 | 13 | $413K |
| Otezla Apremilast | 68 | 86 | Under 11 | $398K |
| Mupirocin Generic | 65 | 67 | 46 | $411 |
| Clobetasol Propionate Generic | 64 | 74 | 36 | $2,649 |
| Minocycline Hcl Generic | 57 | 76 | 26 | $585 |
| Minoxidil Generic | 51 | 65 | Under 11 | $336 |
| Tacrolimus Generic | 51 | 51 | 28 | $5,349 |
| Cephalexin Generic | 51 | 51 | 30 | $372 |
Brand drugs: 404 claims; generic drugs: 1,902 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nancy H Trzcinski $1,023 ($1,023 in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $253.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 19 | $253 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $186 |
| Abbvie Inc. ABBV | 12 | $141 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $129 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $94.99 |
| Organon LLC OGN | 5 | $60.43 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $58.2 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $43.48 |
| Lilly USA, LLC LLY | 1 | $28.71 |
| UCB, Inc. UCB.BR | 1 | $28.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.